[This corrects the article DOI: 10.3389/fonc.2023.1144951.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10740177 | PMC |
| http://dx.doi.org/10.3389/fonc.2023.1339187 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction to: XBP 1-Deficiency Abrogates Neointimal Lesion of Injured Vessels Via Cross Talk With the PDGF Signaling.
Arterioscler Thromb Vasc Biol
October 2024
Erratum: PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma.
Front Oncol
December 2023
[This corrects the article DOI: 10.3389/fonc.2023.
View Article and Find Full Text PDFCorrigendum to "New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies" [Biomed. Pharmacother. 161 (2023) 114491].
Biomed Pharmacother
November 2023
Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea. Electronic address:
Corrigendum: Dendritic cell proliferation by primary cilium in atopic dermatitis.
Front Mol Biosci
August 2023
Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
[This corrects the article DOI: 10.3389/fmolb.2023.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!